LXRX Q2 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$234,000-97.4% YoY

Gross Profit

-$10M-4283.3% margin

Operating Income

-$18M-7674.8% margin

Net Income

-$18M-7720.9% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+766.7%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$172M

Total Liabilities

$34M

Stockholders' Equity

$137M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$234,000	$9M	-97.4%
Gross Profit	-$10M	$8M	-218.8%
Operating Income	-$18M	-$65M	+72.2%
Net Income	-$18M	-$69M	+73.8%